Biosimulytics Limited is a spin-out company founded in 2019 from the School of Chemical & Bioprocess Engineering of University College Dublin (UCD) in Ireland. The company is specialising in the deployment of Artificial Intelligence (AI) combined with molecular modelling, quantum physics and high performance computing, for the digitisation of next-generation drug development in the pharma/biotech sector, helping to unlock new and improved therapies faster and more cost efficiently, in order to address the pressing healthcare needs of society.